2024 graduates of the MSK School of Radiation Therapy
Memorial Sloan Kettering Cancer Center (MSKCC) shared on X:
“Congratulations to 2024 graduates of the MSK School of Radiation Therapy, which has produced hundreds of radiation therapists over the past five decades. This program shows the dedication and expertise of the faculty and leaders in radiation oncology.
More.”
Source: MSKCC/X
Founded in 1884 Memorial Sloan Kettering Cancer Center (MSK or MSKCC) is a renowned cancer treatment and research facility located in Manhattan, New York City. With over 120 research laboratories, it is globally recognized for its dynamic cancer research program.
MSK has pioneered numerous treatment advances, including radiation therapy, chemotherapy, immunotherapy, and precision medicine. Recent successes include the development of checkpoint inhibitors and CAR T cells.
For over 30 years, MSK has consistently been ranked the second-best hospital for cancer care in the US by U.S. News and World Report’s Best Hospitals rankings.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023